Michael has extensive commercial, research and teaching experience gained in the USA and Australia. Since 2015, Michael has held the position of Adjunct Professor at the University of Melbourne, where he teaches entrepreneurship to MBA students at the Melbourne Business School and to graduate students at the School of Engineering and the School of Information. He also co-teaches bio-design innovation.
Previously, Michael was a Professor and Director at Monash University, with positions at the Monash Asia-Pacific Centre for Science and Wealth Creation (2006 to 2012) and the Faculty of Information Technology (2008 to 2015). Michael has also held various consultancy, management, commercial and teaching roles in the USA, including Harvard Business School, Prudential Insurance Company of America, and the Ernst & Young Centre for Business Innovation.
Michael has written or contributed to various books and written a large number of professional publications, journal articles, conference papers and case studies.
Michael has acted as a Non-Executive Director in listed and unlisted companies, including ASX-listed Medical Therapies Ltd (now called Cellmid), which he chaired from 2005 to 2008. The company was involved in the commercialisation of anti-inflammatory and anti-cancer therapeutics and entered clinical trials with its first product in February 2008.
Michael holds tertiary qualifications in mathematics from Oakland University in Michigan (BA) and Dartmouth College in New Hampshire (PhD), and an MBA from Harvard Business School.